<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v43-2012-12-04.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.3 2012-12-04" file="US20140004566A1-20140102.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20131218" date-publ="20140102"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20140004566</doc-number><kind>A1</kind><date>20140102</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>13732912</doc-number><date>20130102</date></document-id></application-reference><us-application-series-code>13</us-application-series-code><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>C</section><class>12</class><subclass>P</subclass><main-group>21</main-group><subgroup>00</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>C</section><class>12</class><subclass>P</subclass><main-group>21</main-group><subgroup>005</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc></classifications-cpc><classification-national><country>US</country><main-classification>435 7021</main-classification></classification-national><invention-title id="d0e43">Fusion Partner for Production of Monoclonal Rabbit Antibodies</invention-title><us-related-documents><continuation><relation><parent-doc><document-id><country>US</country><doc-number>13274946</doc-number><date>20111017</date></document-id><parent-grant-document><document-id><country>US</country><doc-number>8367408</doc-number></document-id></parent-grant-document></parent-doc><child-doc><document-id><country>US</country><doc-number>13732912</doc-number></document-id></child-doc></relation></continuation><continuation><relation><parent-doc><document-id><country>US</country><doc-number>12755212</doc-number><date>20100406</date></document-id><parent-grant-document><document-id><country>US</country><doc-number>8062867</doc-number></document-id></parent-grant-document></parent-doc><child-doc><document-id><country>US</country><doc-number>13274946</doc-number></document-id></child-doc></relation></continuation><continuation><relation><parent-doc><document-id><country>US</country><doc-number>12196234</doc-number><date>20080821</date></document-id><parent-grant-document><document-id><country>US</country><doc-number>7732168</doc-number></document-id></parent-grant-document></parent-doc><child-doc><document-id><country>US</country><doc-number>12755212</doc-number></document-id></child-doc></relation></continuation><division><relation><parent-doc><document-id><country>US</country><doc-number>11476277</doc-number><date>20060627</date></document-id><parent-grant-document><document-id><country>US</country><doc-number>7429487</doc-number></document-id></parent-grant-document></parent-doc><child-doc><document-id><country>US</country><doc-number>12196234</doc-number></document-id></child-doc></relation></division><us-provisional-application><document-id><country>US</country><doc-number>60697014</doc-number><date>20050705</date></document-id></us-provisional-application></us-related-documents><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only" applicant-authority-category="assignee"><addressbook><orgname>Epitomics, Inc.</orgname><address><city>Burlingame</city><state>CA</state><country>US</country></address></addressbook><residence><country>US</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>Pytela</last-name><first-name>Robert</first-name><address><city>San Francisco</city><state>CA</state><country>US</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>Zhu</last-name><first-name>Weimin</first-name><address><city>San Francisco</city><state>CA</state><country>US</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>Ke</last-name><first-name>Yaohuang</first-name><address><city>San Francisco</city><state>CA</state><country>US</country></address></addressbook></inventor><inventor sequence="03" designation="us-only"><addressbook><last-name>Qi</last-name><first-name>Qian</first-name><address><city>San Francisco</city><state>CA</state><country>US</country></address></addressbook></inventor><inventor sequence="04" designation="us-only"><addressbook><last-name>Au</last-name><first-name>Harry C.</first-name><address><city>San Francisco</city><state>CA</state><country>US</country></address></addressbook></inventor></inventors></us-parties></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">The invention provides a rabbit-derived immortal B-lymphocyte capable of fusion with a rabbit splenocyte to produce a hybrid cell that produces an antibody. The immortal B-lymphocyte does not detectably express endogenous immunoglobulin heavy chain and may contain, in certain embodiments, an altered immunoglobulin heavy chain-encoding gene. A hybridoma resulting from fusion between the subject immortal B-lymphocyte and a rabbit antibody-producing cell is provided, as is a method of using that hybridoma to produce an antibody. The subject invention finds use in a variety of different diagnostic, therapeutic and research applications.</p></abstract></us-patent-application>